{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:24:21Z","timestamp":1791329061392,"version":"4.3.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Melasma is a common relapsing hyperpigmentation disorder, which is often difficult to treat. Platelet-rich plasma (PRP) is a novel modality often used to treat acne scars, androgenic alopecia, chronic wounds, and skin rejuvenation. Recently, it has had a promising role in the treatment of melasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To review the published evidence on the efficacy and safety of PRP in the treatment of melasma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A systematic review was performed. A meta-analysis could not be performed because of methodological differences across studies and data heterogeneity<jats:bold>.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Seven studies were fulfilled and analyzed. Most studies used intradermal injections of PRP and have shown significant improvement in melasma. Microneedling mediated delivery of PRP has been tried in melasma with good results. A single study showed no additional benefit of PRP in patients treated with topical tranexamic acid. Another study showed no benefit of intense pulsed light in patients treated with intradermal PRP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Platelet-rich plasma inhibits the melanin synthesis through its various components acting through several mechanisms. It demonstrates a moderate grade of recommendation according to the Oxford Center for Evidence-Based Medicine 2011 standards.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000003266","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T07:04:43Z","timestamp":1635836683000},"page":"131-134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["Platelet-Rich Plasma in Melasma\u2014A Systematic Review"],"prefix":"10.1097","volume":"48","author":[{"given":"Rashmi","family":"Sarkar","sequence":"first","affiliation":[{"name":"Dermatology, Venereology and Leprology, Lady Hardinge Medical College, New Delhi, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna","family":"Gupta","sequence":"additional","affiliation":[{"name":"GS Medical College, Hapur, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1590\/abd1806-4841.20143063","article-title":"Melasma: a clinical and epidemiological review","volume":"89","author":"Handel","year":"2014","journal-title":"An Bras Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjd.13059","article-title":"Risk factors for facial melasma in women: a case-control study","volume":"171","author":"Handel","year":"2014","journal-title":"Br J Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2349-5847.159389","article-title":"Etiopathogenesis of melasma","volume":"2","author":"Sonthalia","year":"2015","journal-title":"Pigment Int"},{"key":"R4-20250731","first-page":"E73","article-title":"Tranexamic acid for melasma: evaluating the various formulations","volume":"12","author":"Wang","year":"2019","journal-title":"J Clin Aesthet Dermatol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00008505-200110000-00002","article-title":"Platelet-rich plasma (PRP): what is PRP and what is not PRP?","volume":"10","author":"Marx","year":"2001","journal-title":"Implant Dent"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1515\/med-2016-0048","article-title":"Platelet Rich Plasma: a short overview of certain bioactive components","volume":"11","author":"Pavlovic","year":"2016","journal-title":"Open Med (Wars)"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5021\/ad.2011.23.4.424","article-title":"Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0974-2077.112671","article-title":"Autologous platelet rich plasma in chronic venous ulcers: study of 17 cases","volume":"6","author":"Sarvajnamurthy","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"key":"R9-20250731","first-page":"177","article-title":"Combined use of skin needling and platelet-rich plasma in acne scarring treatment","volume":"24","author":"Fabbrocini","year":"2011","journal-title":"J Cosmet Dermatol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/jocd.13157","article-title":"Platelet-rich plasma treatment for melasma: a pilot study","volume":"19","author":"Sirithanabadeekul","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"R11-20250731","first-page":"348","article-title":"Efficacy of platelet-rich plasma in the treatment of melasma: a pilot study","volume":"28","author":"Faiz","year":"2017","journal-title":"J Pakistan Assoc Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/09546634.2018.1524821","article-title":"Platelet-rich plasma is a useful therapeutic option in melasma","volume":"30","author":"Hofny","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"e14358","DOI":"10.1111\/dth.14358","article-title":"Evaluation of therapeutic outcome of transepidermal administration of platelet-rich plasma with microneedling in melasma","volume":"33","author":"Boparai","year":"2020","journal-title":"Dermatol Ther"},{"key":"R14-20250731","first-page":"1","article-title":"Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma","author":"Gamea","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"R15-20250731","first-page":"3","article-title":"Platelet rich-plasma (PRP) in treatment of melasma","volume":"3","author":"Adel","year":"2017","journal-title":"J Cosmo Trichol"},{"key":"R16-20250731","first-page":"1482","article-title":"Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation","volume":"36","author":"Kim","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molcel.2008.11.002","article-title":"Inhibition of PAX3 by TGF-beta modulates melanocyte viability","volume":"32","author":"Yang","year":"2008","journal-title":"Mol Cell"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/dsu.12348","article-title":"Epidermal growth factor and epidermal growth factor signaling attenuate laser-induced melanogenesis","volume":"39","author":"Yun","year":"2013","journal-title":"Dermatol Surg"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/14764172.2019.1668016","article-title":"Increased expression of TGF-\u03b2 protein in the lesional skins of melasma patients following treatment with platelet-rich plasma","volume":"21","author":"Hofny","year":"2019","journal-title":"J Cosmet Laser Ther"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:10:39Z","timestamp":1753999839000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000003266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000003266","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]}}}